168 related articles for article (PubMed ID: 31510873)
1. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
Calvete O; Martinez P; Garcia-Pavia P; Benitez-Buelga C; Paumard-Hernández B; Fernandez V; Dominguez F; Salas C; Romero-Laorden N; Garcia-Donas J; Carrillo J; Perona R; Triviño JC; Andrés R; Cano JM; Rivera B; Alonso-Pulpon L; Setien F; Esteller M; Rodriguez-Perales S; Bougeard G; Frebourg T; Urioste M; Blasco MA; Benítez J
Nat Commun; 2015 Sep; 6():8383. PubMed ID: 26403419
[TBL] [Abstract][Full Text] [Related]
3. The wide spectrum of POT1 gene variants correlates with multiple cancer types.
Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
[TBL] [Abstract][Full Text] [Related]
4. A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus.
Takai H; Jenkinson E; Kabir S; Babul-Hirji R; Najm-Tehrani N; Chitayat DA; Crow YJ; de Lange T
Genes Dev; 2016 Apr; 30(7):812-26. PubMed ID: 27013236
[TBL] [Abstract][Full Text] [Related]
5. A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations.
Martínez P; Sánchez-Vázquez R; Ferrara-Romeo I; Serrano R; Flores JM; Blasco MA
PLoS Genet; 2022 Jun; 18(6):e1010260. PubMed ID: 35727838
[TBL] [Abstract][Full Text] [Related]
6. Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.
Pinzaru AM; Hom RA; Beal A; Phillips AF; Ni E; Cardozo T; Nair N; Choi J; Wuttke DS; Sfeir A; Denchi EL
Cell Rep; 2016 Jun; 15(10):2170-2184. PubMed ID: 27239034
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.
Guo X; Deng Y; Lin Y; Cosme-Blanco W; Chan S; He H; Yuan G; Brown EJ; Chang S
EMBO J; 2007 Nov; 26(22):4709-19. PubMed ID: 17948054
[TBL] [Abstract][Full Text] [Related]
8. A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.
Kunze K; Spieker T; Gamerdinger U; Nau K; Berger J; Dreyer T; Sindermann JR; Hoffmeier A; Gattenlöhner S; Bräuninger A
Cancer Res; 2014 Nov; 74(21):6173-83. PubMed ID: 25252913
[TBL] [Abstract][Full Text] [Related]
9.
Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
[TBL] [Abstract][Full Text] [Related]
10. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
Denchi EL; de Lange T
Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.
Kim WT; Hennick K; Johnson J; Finnerty B; Choo S; Short SB; Drubin C; Forster R; McMaster ML; Hockemeyer D
EMBO J; 2021 Jun; 40(12):e107346. PubMed ID: 33934394
[TBL] [Abstract][Full Text] [Related]
12. RPA and POT1: friends or foes at telomeres?
Flynn RL; Chang S; Zou L
Cell Cycle; 2012 Feb; 11(4):652-7. PubMed ID: 22373525
[TBL] [Abstract][Full Text] [Related]
13. Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies.
Zhrebker L; Cherni I; Gross LM; Hinshelwood MM; Reese M; Aldrich J; Guileyardo JM; Roberts WC; Craig D; Von Hoff DD; Mennel RG; Carpten JD
BMC Cancer; 2017 Jan; 17(1):17. PubMed ID: 28056866
[TBL] [Abstract][Full Text] [Related]
14. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.
Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003
[TBL] [Abstract][Full Text] [Related]
15. Pot1 and cell cycle progression cooperate in telomere length regulation.
Churikov D; Price CM
Nat Struct Mol Biol; 2008 Jan; 15(1):79-84. PubMed ID: 18066078
[TBL] [Abstract][Full Text] [Related]
16. Protection of telomeres 1 proteins POT1a and POT1b can repress ATR signaling by RPA exclusion, but binding to CST limits ATR repression by POT1b.
Kratz K; de Lange T
J Biol Chem; 2018 Sep; 293(37):14384-14392. PubMed ID: 30082315
[TBL] [Abstract][Full Text] [Related]
17. Familial Clonal Hematopoiesis in a Long Telomere Syndrome.
DeBoy EA; Tassia MG; Schratz KE; Yan SM; Cosner ZL; McNally EJ; Gable DL; Xiang Z; Lombard DB; Antonarakis ES; Gocke CD; McCoy RC; Armanios M
N Engl J Med; 2023 Jun; 388(26):2422-2433. PubMed ID: 37140166
[TBL] [Abstract][Full Text] [Related]
18. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA.
Flynn RL; Centore RC; O'Sullivan RJ; Rai R; Tse A; Songyang Z; Chang S; Karlseder J; Zou L
Nature; 2011 Mar; 471(7339):532-6. PubMed ID: 21399625
[TBL] [Abstract][Full Text] [Related]
19. Bacterial quorum-sensing signal IQS induces host cell apoptosis by targeting POT1-p53 signalling pathway.
Wang J; Wang C; Yu HB; Dela Ahator S; Wu X; Lv S; Zhang LH
Cell Microbiol; 2019 Oct; 21(10):e13076. PubMed ID: 31254473
[TBL] [Abstract][Full Text] [Related]
20. Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia.
Wang T; Mei SC; Fu R; Wang HQ; Shao ZH
J Immunol Res; 2014; 2014():439530. PubMed ID: 24892036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
